Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial

被引：0
|
作者：
A. Hasenburg
D. Eichkorn
F. Vosshagen
E. Obermayr
A. Geroldinger
R. Zeillinger
M. Bossart
机构：
[1] University Medical Center,Department of Obstetrics and Gynecology
[2] Department of Obstetrics and Gynecology,Department of Anesthesiology
[3] Schwarzwald-Baar Clinics,Department of Obstetrics and Gynecology
[4] Ortenau Clinics,Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems
[5] Medical University of Vienna,Department of Obstetrics and Gynecology
[6] Medical University of Vienna,undefined
[7] University Medical Center,undefined
来源：
BMC Cancer | / 21卷
关键词：
Ovarian cancer; Biomarker; Protein panel; CA125; Liquid biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 46 条
  • [31] SA02 Trial: A Genomics-Based Prospective Study of Adjuvant Chemotherapy in Node-Positive Early Breast Cancer with "Good-Prognosis Signature"
    Francois, B.
    Marc, Jean E.
    Marc, Jean F.
    Thomas, B.
    Xavier, T.
    Tarpin, C.
    Agnes, T.
    Jocelyne, J.
    Eric, L.
    Benjamin, E.
    Isabelle, O.
    Agnes, M.
    Patrice, V
    CANCER RESEARCH, 2009, 69 (24) : 720S - 720S
  • [32] Chemotherapy directed by the ATP-based tumor chemosensitivity assay versus physician's choice in platinum-resistant ovarian carcinoma: a multicenter prospective randomized controlled trial of the TCA ovarian cancer trial group
    Kurbacher, C. M.
    Cree, I. A.
    Lamont, A.
    Hindley, A. C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 268 - 268
  • [33] SA02 trial: Results of a genomics-based prospective cohort in node-positive early breast cancer with "good-prognosis signature" treated with adjuvant chemotherapy
    Francois, Bertucci
    Jean-Marc, Extra
    Jean-Marc, Ferrero
    Thomas, Bachelot
    Aurelie, Autret
    Agnes, Boyer-Chammard
    Patrice, Viens
    CANCER RESEARCH, 2015, 75
  • [34] Fluorescence immunoassay based on nitrogen doped carbon dots for the detection of human nuclear matrix protein NMP22 as biomarker for early stage diagnosis of bladder cancer
    Othman, Hazha Omar
    Salehnia, Foad
    Hosseini, Morteza
    Hassan, Rebwar
    Faizullah, Azad
    Ganjali, Mohammad Reza
    MICROCHEMICAL JOURNAL, 2020, 157
  • [35] A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial
    Kim, Chang Woo
    Kim, Hyunjin
    Kim, Hyoung Rae
    Won, Daeyeon David
    Nam, Woo Jung
    Min, Byung Soh
    Oh, Tae Jeong
    An, Sungwhan
    Lee, Suk-Hwan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (03): : 614 - 622
  • [36] Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection
    Claudia Fredolini
    Khyatiben V. Pathak
    Luisa Paris
    Kristina M. Chapple
    Kristine A. Tsantilas
    Matthew Rosenow
    Tony J. Tegeler
    Krystine Garcia-Mansfield
    Davide Tamburro
    Weidong Zhou
    Paul Russo
    Samuele Massarut
    Francesco Facchiano
    Claudio Belluco
    Ruggero De Maria
    Enrico Garaci
    Lance Liotta
    Emanuel F. Petricoin
    Patrick Pirrotte
    Breast Cancer Research, 22
  • [37] Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection
    Fredolini, Claudia
    Pathak, Khyatiben, V
    Paris, Luisa
    Chapple, Kristina M.
    Tsantilas, Kristine A.
    Rosenow, Matthew
    Tegeler, Tony J.
    Garcia-Mansfield, Krystine
    Tamburro, Davide
    Zhou, Weidong
    Russo, Paul
    Massarut, Samuele
    Facchiano, Francesco
    Belluco, Claudio
    De Maria, Ruggero
    Garaci, Enrico
    Liotta, Lance
    Petricoin, Emanuel F.
    Pirrotte, Patrick
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [38] Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69 Yr:The PSAInForm Trial
    Semjonow, Axel
    Hense, Hans-Werner
    Schloessler, Kathrin
    Simbrich, Alexandra
    Borowski, Matthias
    Bothe, Christiane
    Kruse, Klaus
    Tiedje, Dorothee
    Kuss, Kathrin
    Adarkwah, Charles Christian
    Maisel, Peter
    Jendyk, Ralf
    Kurosinski, Marc-Andre
    Gerss, Joachim
    Heidinger, Oliver
    Tschuschke, Christian
    Becker, Ralf
    Roobol, Monique J.
    Bangma, Chris
    Donner-Banzhoff, Norbert
    EUROPEAN UROLOGY, 2019, 76 (01) : 1 - 3
  • [39] Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial
    Neal, Richard D.
    Johnson, Peter
    Clarke, Christina A.
    Hamilton, Stephanie A.
    Zhang, Nan
    Kumar, Harpal
    Swanton, Charles
    Sasieni, Peter
    CANCERS, 2022, 14 (19)
  • [40] Effects of an interactive mHealth innovation for early detection of patient-reported symptom distress with focus on participatory care: protocol for a study based on prospective, randomised, controlled trials in patients with prostate and breast cancer
    Langius-Eklof, Ann
    Crafoord, Marie-Therese
    Christiansen, Mats
    Fjell, Maria
    Sundberg, Kay
    BMC CANCER, 2017, 17
12345